Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure

J Card Fail. 2007 Nov;13(9):701-8. doi: 10.1016/j.cardfail.2007.06.722.

Abstract

Background: The enhancement of circulating endothelial progenitor cells (EPCs) obtained by exercise training can be beneficial to patients with cardiac disease. Changes in the levels and differentiation of CD34(pos)/KDR(pos) EPCs, as well as the plasma concentration of vascular endothelial growth factor (VEGF) and stromal cell-derived factor (SDF)-1 EPC-mobilizing cytokines, were evaluated in patients with chronic heart failure after 8 weeks of supervised aerobic training (SAT) and 8 weeks of subsequent discontinued SAT (DSAT).

Methods and results: The levels of circulating EPC and EPC differentiation potential of 22 patients who underwent SAT were studied by fluorescence-activated cell sorter analysis and colony forming-unit assay, respectively. The plasma levels of VEGF and SDF-1 were measured by enzyme-linked immunosorbent assay. In response to SAT, the levels of both EPC and VEGF/SDF-1 markedly increased (P < .001 vs baseline) but returned to the baseline levels after DSAT. A similar change was observed with the EPC clonogenic potential, but on DSAT the baseline level was incompletely attained.

Conclusions: In response to SAT, patients with chronic heart failure show enhanced EPC levels and clonogenic potential that is mirrored by increased plasma VEGF and SDF-1 levels. DSAT can interfere with the maintenance of training-acquired VEGF/SDF-1-related EPC levels and clonogenic potential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines / biosynthesis
  • Endothelial Cells / cytology*
  • Endothelium / physiology*
  • Exercise / physiology*
  • Female
  • Flow Cytometry
  • Heart Failure / therapy*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Stem Cells / cytology*
  • Time Factors
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Cytokines
  • Vascular Endothelial Growth Factor A